Q2 2022
Released Aug 12, 2022, before the open
10-Q filed Aug 12, 2022, 43 days after period end · 0001789769-22-000069
Q2 2022 · 10-Q
Revenue—
Net Income-$58.99M-$58.99M N/M vs Q2 2021N/M vs Q1 2022
EPS Diluted-$0.46-$0.46 N/M vs Q2 2021N/M vs Q1 2022
Operating Income-$58,724,000N/M
Operating Cash Flowderived-$47,260,000N/M
Free Cash Flowderived-$73,403,000N/M
What the release said
The release
Same quarter
| Metric | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|
| Revenue | — | $0.00 | $42.00K |
| Net Income | -$58.99M | -$35.31M | -$9.20M |
| EPS Diluted | -$0.46 | -$0.27 | -$0.55 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Instil Bio, Inc. · CIK 1789769 · Engraved from SEC EDGAR